Birdwatch Note Rating
2023-05-20 00:27:20 UTC - NOT_HELPFUL
Rated by Participant: 38E769B10DFDAE732653122D5831203F2E9ED4962619C723C16625AF6FB4F958
Participant Details
Original Note:
The reactogenicity subset consisted of 8,183 persons. Severe disease subset was the entire cohort (N=43,355) The severe disease endpoint was 30-1 in favor of placebo for 96.7% reduction in 6 month follow up data https://www.nejm.org/doi/suppl/10.1056/NEJMoa2034577/suppl_file/nejmoa2034577_appendix.pdf https://www.nejm.org/doi/full/10.1056/nejmoa2110345
All Note Details